ESSA Pharma Inc(NASDAQ:EPIX) 
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prosta...
Website: http://www.essapharma.com
Founded: 2009
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.55
H 1.59
L 1.43
C 1.48
V 311,557
10EMA 1.48
20EMA 1.48
60EMA 1.48
120EMA 1.48
250EMA 1.48